Papillary Renal Cell Carcinoma Not Yet Recruiting Phase 2 Trials for Cabozantinib (DB08875)

IndicationStatusPhase
DBCOND0030667 (Papillary Renal Cell Carcinoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs